International Conference on Autoimmunity October 13-14, 2016 Manchester, UK

Sylviane Muller received her doctoral degrees in Molecular Biology (1978) and Science (1984) from the University of Strasbourg (France). She worked as a post-doctoral fellow at the Max-Planck Institute for Immunobiology in Freiburg (Germany). She is currently Distinguished class Research Director at the CNRS and Professor at the Institute of Advanced Studies of the Strasbourg University (chair Therapeutic immunology). She is deputy director of the Molecular and Cellular Biology Institute, Director of the CNRS Unit Immunopathology and therapeutic chemistry, and Head of the Drug discovery center for cancer and inflammation Medalis awarded 'Laboratory of Excellence’. Her research interests focus on molecular and cellular events involved in autoimmunity, especially in the lupus disease. She discovered the P140/Lupuzor peptide that is currently evaluated in a phase III clinical trial for lupus. She is the co-author of over 345 publications, co-inventor of ~30 patents and co-founder of NeoMPS (1986) and ImmuPharma (2002) companies. She received the CNRS Silver Medal (2009) and the CNRS Innovation Award (2015).

molecular and cellular events involved in autoimmunity, especially in the lupus disease. She discovered the P140/Lupuzor peptide that is currently evaluated in a phase III clinical trial for lupus

Angela Lee Foreman, Ph.D. is an Immunologist with specialty within Autoimmune Disease and Infectious Diseases, augmented by exposure to environmental contaminants. Dr. Foreman received her Ph.D. from University of California at Davis in 2007 for her investigative work into the sequences of antibody variable region within Primary Biliary Cirrhosis (PBC). During that time, she worked on collaborative research project at several institutions that included National Oceanic Atmospheric Administration (NOAA) in Newport, Oregon investigating into the antibody response of the Chinook salmon to the local pathogen when exposed to common contaminant within the river; L’Institut Pasteur in Paris, France to work on collaborative project in applying spectratyping technique in identifying the specific antibody sequence within PBC autoimmune disease in humans; University of Michigan, Ann Arbor to investigate the cellular signaling pathway within the Outer Hair Cells (OHC) within the cochlea as an indicator of hearing loss in mice; UC Davis Center for Comparative Medicine to investigate into the antibody response to the influenza virus within the local Mesenteric lymph node in mice. Then, Dr. Foreman went on to teach at Rochester Institute of Technology (RIT) for several years while including undergraduates within her research projects. At RIT, Dr. Foreman investigated into the CCR5 delta-32 deletion within Primary sclerosing cholangitis (PSC) in human samples, and antibody variable region response in frog model. Upon Dr. Foreman’s return to the Bay Area, her most recent projects include as a consultant for a stem-cell research for a pharmaceutical start-up; and Principal Investigator / Study Director for Clinical Research Study for a medical device start-up.

Immunology, Autoimmunity,Infectious Diseases,

Alessandro Antonelli (Professor, MD) completed the degree in Medicine, cum laude, in 1982, the Specialization in Endocrinology in 1985, the Specialization in Occupational Health in 1987, and the Specialization in Oncology in 1992, at the University of Pisa, Pisa, Italy. He is now Associate Professor in the Department of Clinical and Experimental Medicine at the University of Pisa. His researches have been published in more than 260 articles on International journals (Impact Factor > 850). He serves as an editorial board member and is Referee and Reviewer of many scientific International journals.

Autoimmunity,Rheumatology,Physiotherapy, Immunology

Anthony Shock received his PhD in Biochemistry from the University of London in 1987 followed by post-doctoral work at the National Heart & Lung Institute in London. He was then employed by a Biotech company called Celltech which eventually transformed into the global biopharmaceutical company, UCB. He has researched on a wide range of drug targets, both small molecule- and antibody-based therapies, including two antibody targets that have been evaluated in patients with systemic lupus erythematosus, namely epratuzumab and dapirolizumab pegol.

Autoimmunity; monoclonal antibodies; lupus; immunology.

Fallah-Arani Farnaz, is currently a senior group leader in the Therapeutic area of immunology at UCB Celltech in Slough and has experience in pre-clinical research and drug discovery of biologics and small molecules. Farnaz is an Immunologist by training and has a strong interest in the biology of autoimmune disease and transplantation.

Immunology, Autoimmune Disorders,Transplantation,Biology,

Dr. Golan has completed his PhD in Cell Research and Immunology, Tel-Aviv University and postdoctoral studies in Hebrew University Medical School of Jerusalem and B.T.G. Israel Ltd. He was holding, during the years, the following academic and other positions; lecturer in Hebrew University Medical School, Honorary Principal Research Fellow in Imperial College, Honorary Senior Lecturer in College of Medicine, Swansea University, R&D/Innovation Manager in Swansea University, Senior Program Manager in NIHR. Dr. Golan is a founder and director of two British Biotechnology Companies developing new biological drugs for autoimmune inflammatory diseases and cancer and serving as an expert/projects evaluator in EU Commission in Brussels. He was awarded for his professional success by Hebrew University and EU Commission. Dr. Golan has published 15 papers in scientific journals, has 36 patents in the field of rheumatoid arthritis and cancer and has been serving as an editorial board member of MOJ Immunology.

Immunology, Autoimmune Disorders,

Senior Staff Scientist, Department of Immunology, The Weizmann Institute of Science, Israel. BSc in Biology in Biology, Hebrew University, Jerusalem, Israel. MSc and PhD in Life Sciences, The Weizmann Institute of Science, Rehovot, Israel. Postdoctoral research, Stanford University, CA, USA. Main research interests: Autoimmunity; Neuroimmunology; Pathology and therapy of multiple sclerosis (MS) and its model experimental autoimmune encephalomyelitis (EAE); immunomodulation, neuroprotection and repair processes in the Central Nervous System; Inflammatory bowel diseases (IBD). Published more than 60 papers and reviews on these subjects. Editorial board member of 20 journals.

: Autoimmunity; Neuroimmunology; Pathology and therapy of multiple sclerosis (MS) and its model experimental autoimmune encephalomyelitis (EAE); immunomodulation, neuroprotection and repair processes in the Central Nervous System; Inflammatory bowel diseases (IBD).

Dr. KUO, Ho-Chang Kuo, MD, PhD, FAAAAI graduated from National Yang-Ming University, Taiwan with a M.D. degree in 1999 and PhD degree from Graduate Institute of Clinical Medical Science at Chang Gung University, Taiwan in 2011. Dr. Kuo worked as an attending pediatrician, physician scientist and associate Professor at Kaohsiung Chang Gung Memorial Hospital and Chang Gung University, Taiwan. Now, I am also the Director of “Kawasaki Disease Center” of Kaohsiung Chang Gung Memorial Hospital, Taiwan. My research interesting was mainly focus on Kawasaki disease. I had published more than 110 peer-reviewed SCI journal papers including 2 Nature Genetics (2011 and 2012), 1 Circulation Research, 1 Arthritis and Rheumatology, 2 Allergy and 65 Kawasaki disease papers. I am ranked as 1st Top Expert of Kawasaki disease in Asia by Expertscape.com.

Allergy, Immunology and Rheumatology,Asthma,Autoimmunity, Kawasaki Diseases.

Guixiu Shi has completed his PhD at University of Montreal, Canada, and finished his postdoc at The Trudeau Institute, USA. He is professor and Chair of the department of rheumatology and clinical immunology in The First Affiliated Hospital of Xiamen University. He serves as vice director of the professor committee in the medical school of Xiamen University. He has published more than 50 papers in peer-reviewed journals including JEM, Blood and JI. His research interest covers immune regulation and autoimmunity.

Autoimmunity,autoimmune disease,rheumatoid arthritis

Luigi Laino is currently working as Surgeon Specialist in Dermatology and Venereology at Latuapelle Dermatologic and Venereologic Centre Rome, Italy. He is also working as Medical Director of the hospital and treatment Institute scientific with High Specialization Assignment in Thermography and Director Dermatological Centre Venereologico Rome Via Bixio 95 - Accredited Lazio Region and ASL Roma 1. He is the Member of Editorial Board SM Dermatology Journal and Secretary of the Italian Federation of Sports Dermatology.

Dermatology, Oncology, Dermatoscopy, Clinical Thermology,

Ljudmila Stojanovich received her Ph.D. in Medicine, with the thesis “Neuropsychiatric manifestations in patients with Systemic Lupus Erythematosus” in 1999. She is the scientific director in the Bezhanijska Kosa, University Medical Center of Belgrade University, where she is currently a Research Professor. Dr. Stojanovich’s research focuses on Systemic Lupus Erythematosus, Antiphospholipid Syndrome, and Vaccination in patients with Autoimmune Rheumatic diseases. She is an author of three monographs and of about 250 articles on various aspects of Autoimmune Rheumatic disorders, published in international and domestic journals and in conference proceedings. She is in Editorial Boards (Editorial Boards LUPUS (LONDON). /Reviewer in the “CURRENT CONTENSTS” or “Science citation index”, like LUPUS REWIEWER DATABAS, Cellular and Molecular Neurobiology, The Journal of Vaccine

SYSTEMIC LUPUS ERYTHEMATOSUS, ANTIPHOSPHOLIPID SYNDROME, VACCINATION IN PATIENTS WITH AUTO-IMMUNE ,INFLAMMATORY RHEUMATIC DISEASES

Ramune Sepetiene is MD with medical laboratory specialization obtained in 1999 at Lithuanian University of Health Sciences, Medicine Academy.Clinical work experience within immunology, hematology and genetics more than 15 years.She is a junior researcher in Laboratory of Molecular Cardiology, Institute of Cardiology, LUHS and part time- laboratory MD position in patients’ clinic. Last year published 4 papers in reputed journals of cardiac surgery, genetics and multidisciplinary research fields.Currently doing PhD at Lithuanian University of Health Sciences.Title of the dissertation “Investigation of FBN1 polymorphisms and TGFß1 concentration in patients with the dilatative pathology within the ascending thoracic aorta”.

Immunology, Cardiology, Autoimmunity, Autoimmune disorders, genetics and multidisciplinary research ,